文献速递血管炎

多中心研究改进PR3与MPO-ANCA临床解读

A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

该多中心研究基于251例AAV患者和924例疾病对照的样本,评估7家公司8种PR3/MPO-ANCA免疫分析,按预设特异性确定抗体阈值并计算结果区间特异性似然比。结果显示抗体水平越高AAV似然比越高,免疫分析联合IIF或另一种免疫分析可提高AUC。

要点

  • 按预设特异性95%、97.5%、99%、100%确定抗体阈值,划分结果区间并计算区间特异性似然比。
  • 所有检测方法中,AAV似然比随抗体水平升高而增加,除一种外多数方法高抗体水平(LR>55)见于>65%患者。
  • 免疫分析阳性后以IIF或另一免疫分析确认的AUC未显著高于仅做免疫分析,免疫分析联合另一免疫分析或IIF时AUC最高。

核心结论

  • 基于PR3和MPO-ANCA诊断AAV时,定义抗体水平阈值并赋予检测结果区间特异性似然比有助于改善临床解读。
  • 抗体水平越高,AAV的患病可能性越高。

研究设计与样本

  • 多中心研究,使用251例AAV患者诊断样本和924例疾病对照,评估7家公司8种PR3/MPO-ANCA免疫分析。
  • 按预设特异性95%、97.5%、99%和100%确定抗体阈值,划分检测结果区间并计算区间特异性似然比。

主要发现

  • 所有检测方法中,AAV的似然比随抗体水平升高而增加。
  • 除一种免疫分析外,高抗体水平(关联LR>55)见于>65%的患者。
  • 免疫分析阳性后以IIF或另一免疫分析确认的诊断策略AUC未显著高于仅做免疫分析。
  • 免疫分析联合另一免疫分析或联合IIF时AUC最高。

关键数值与推荐

  • 预设特异性95%、97.5%、99%和100%用于确定抗体水平阈值并界定检测结果区间。
  • 高抗体水平关联LR>55,且除一种方法外见于>65%的患者。

临床怎么用

  • 临床解读PR3/MPO-ANCA时应结合抗体水平阈值和结果区间特异性似然比评估AAV可能性。
  • 抗体水平越高,应越考虑AAV诊断。
  • 免疫分析联合另一种免疫分析或IIF可能提高诊断效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this multicentre study was to improve the clinical interpretation of PR3- and MPO-ANCAs as an adjunct for the diagnosis of ANCA-associated vasculitis (AAV) by defining thresholds and test result intervals based on predefined specificities and by calculating test result interval-specific likelihood ratios (LRs). METHODS: Eight different PR3- and MPO-ANCA immunoassays from seven companies were evaluated using 251 diagnostic samples from AAV patients and 924 diseased controls. RESULTS: Thresholds for antibody levels were determined based on predefined specificities (95, 97.5, 99 and 100%) and used to delimit test result intervals. Test result interval-specific LRs were determined. For all assays, the LR for AAV increased with increasing antibody level. For all but one immunoassay, high antibodies levels (associated with LR >55) were found in a substantial fraction (>65%) of patients. The area under the curve (AUC) of receiver operating characteristics analysis of a diagnostic approach in which positive results were confirmed by IIF or another immunoassay was not substantially higher than the AUC of performing immunoassay only. The highest AUC was found when immunoassay was combined with another immunoassay or with IIF. CONCLUSION: To diagnose AAV based on PR3- and MPO-ANCA, it is useful to define thresholds for antibody levels and to assign test result interval-specific LRs. Higher antibody levels are associated with a higher likelihood for disease. Such information improves clinical interpretation.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Bossuyt X, Rasmussen N, van Paassen P, et al. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Rheumatology (Oxford). 2017. PMID: 28541581. doi:10.1093/rheumatology/kex170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。